Cargando…
地西他滨桥接异基因造血干细胞移植治疗骨髓增生异常综合征的疗效分析
OBJECTIVE: To evaluate the efficacy of decitabine (DAC) bridging therapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with myelodysplastic syndrome (MDS). METHODS: The clinical characteristics and curative effect of MDS patients who received allo-HSCT from 2...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342152/ https://www.ncbi.nlm.nih.gov/pubmed/25778887 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.02.008 |